约 7,030,000 个结果
FDA approves ribociclib with an aromatase inhibitor and ribociclib …
Ribociclib Improves Survival in Advanced Breast Cancer
FDA Approves Adjuvant Ribociclib in HR+/HER2– Breast Cancer
Ribociclib Combo Approved in HR+/HER2- Stage II-III Early Breast …
Overall Survival with Ribociclib plus Letrozole in Advanced Breast ...
Kisqali Approved for HR+, HER2- Early Breast Cancer
FDA Approves Ribociclib for Early Breast Cancer Treatment With …
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
Ribociclib plus Endocrine Therapy in Early Breast Cancer
Ribociclib Combo Yields Extended iDFS Benefit in HR+/HER2– …